Refactor Capital

Astranis builds small geostationary broadband satellites (MicroGEO) that are roughly 1/20th the size of traditional GEO spacecraft, drastically reducing manufacturing and launch costs. The company operates the satellites it builds and leases dedicated capacity to telecom and internet service providers, connecting underserved regions worldwide.

Clinical-stage precision oncology company that built a proprietary Predictive Precision Medicines Platform (PPMP) to bio-simulate cancer treatments and predict patient response. Originally tested combinations of FDA-approved drugs on patient cancer cell samples for blood cancers. Demonstrated 84% accuracy in predicting treatment responses with Stanford.